U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07535268) titled 'REPRESENT-PF Registry' on April 09.
Brief Summary: This pragmatic, prospective, single-arm, multi-center, observational registry will evaluate the safety and effectiveness of PFA for the treatment of atrial fibrillation in underrepresented minority patients using FDA approved Boston Scientific PFA catheters; all data collected will be standard of care.
Study Start Date: March 30
Study Type: OBSERVATIONAL
Condition:
Persistent Atrial Fibrillation
Paroxysmal Atrial Fibrillation
Intervention:
DEVICE: FARAWAVE Pulsed Field Ablation Catheter
The FARAWAVE Pulsed Field Ablation (PFA) Catheter is a component of the FARAPULSE PFA Sys...